Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin pharmacokinetics and skeletal muscle mass in head and neck cancer
NL-OMON48724Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cisplatin in head and neck squamous cell carcinoma (HNSCC) and head and neck cancer (HNC), sponsored by University Medical Center Utrecht. Primary endpoints: Association between cisplatin pharmacokinetic properties and body surface area and Association between cisplatin pharmacokinetic properties and skeletal muscle mass. Started Jul 2018; status: active, not recruiting.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)head and neck cancer (HNC)
Beyond the preview
Go deeper on NL-OMON48724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48724.